Industry News
Breast cancer gene holds key to personalised medicine and new drug development
6/15/2016
Nottingham scientists have identified a new breast cancer gene which, when over-expressed or mutated, indicates which patients will benefit from chemotherapy.
Chemotherapy may boost immunotherapy power in ovarian cancer
6/15/2016
Women with advanced ovarian cancer may benefit more from immunotherapy drug treatments if they are given straight after chemotherapy, according to a new study published in Clinical Cancer Research.
Multicenter, Phase II trial suggests autologous transplant should be standard of care for HIV patients with relapsed/treatment-resistant lymphoma.
Texan is first adult in U.S. to receive updated stem cell transplant for leukemia treatment
6/14/2016
Texan Chuck Dandridge became the first adult in the U.S. to receive a newly modified stem cell transplant that uses genetically engineered blood cells from a family member, announced researchers at...
Patients taking tyrosine kinase inhibitors (TKIs) for chronic myeloid leukemia (CML) face an increased risk for arterial and venous vascular events.
Middle aged more likely to be diagnosed with advanced lung cancer
6/14/2016
Youger patients - aged 50 to 64 - are more likely to be diagnosed with late stage lung cancer than older patients according to new data being presented at the Cancer Outcomes and Data Conference in...
New research provides hope for patients with hard-to-treat breast cancer
6/13/2016
Cancer Research UK scientists have found a new way to slow the growth of the most aggressive type of breast cancer, according to research published in the journal Oncogene.
Antibody-based drug helps 'bridge' leukemia patients to curative treatment
6/13/2016
Study reports complete cancer remission rate higher than conventional chemotherapy for acute lymphoblastic leukemia.
Laser ablation becomes increasingly viable treatment for prostate cancer
6/13/2016
Prostate cancer patients may soon have a new option to treat their disease: laser heat.
Acute myeloid leukemia (AML) is an aggressive form of blood cancer. Treatment with intensive chemotherapy often leads to a period of freedom from overt disease called a remission.